Cargando…
Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors
BACKGROUND: The use of baseline tumor burden (TB) as a prognostic factor for non‐small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) and associations between TB and other prognostic biomarkers remain unclear. In this study, we investigated the association between...
Autores principales: | Sakata, Yoshihiko, Kawamura, Kodai, Ichikado, Kazuya, Shingu, Naoki, Yasuda, Yuko, Eguchi, Yoshitomo, Hisanaga, Jumpei, Nitawaki, Tatsuya, Iio, Miwa, Sekido, Yuko, Nakano, Aiko, Sakagami, Takuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885438/ https://www.ncbi.nlm.nih.gov/pubmed/31679185 http://dx.doi.org/10.1111/1759-7714.13214 |
Ejemplares similares
-
The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events
por: Sakata, Yoshihiko, et al.
Publicado: (2018) -
Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia
por: Ichikado, Kazuya, et al.
Publicado: (2021) -
Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis
por: Kawamura, Kodai, et al.
Publicado: (2016) -
Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
por: Nitawaki, Tatsuya, et al.
Publicado: (2017) -
Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
por: Kawamura, Kodai, et al.
Publicado: (2020)